-
www.ahrq.gov/data/resources/index.html?page=2
providers, satisfaction with and access to the usual source of health care provider, and access to medical treatment … , dental treatment, and prescription medicines. … Some are long-term, life-threatening conditions, such as cancer, diabetes, emphysema, high cholesterol
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-235-section-2-tech-specs.pdf
June 02, 2025 - Pediatric Cardiology 2080P0202X
Cardiovascular Disease 207RC0000X
Endocrinology Endocrinology, Diabetes … Office 11
Home 12
Mobile Unit 15
Outpatient Hospital 22
Ambulatory Surgical Center 24
Military Treatment … Federally Qualified Health Center 50
Community Mental Health Center 53
Non-residential Substance Abuse Treatment … Immunization Center 60
Comprehensive Outpatient Rehabilitation Facility 62
End-stage Renal Disease Treatment
-
www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap6tab23.html
December 01, 2017 - All adults
Adults with diabetes
Adults with CVD
Adults with both diabetes and CVD
Adults with … CVD only
Adults with either diabetes or CVD
Average number of ECM visits
0.3
1.2
1.0
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/decision/research-centers/bundlingcps.pdf
March 01, 2014 - Integrating substance abuse care with community diabetes care:
implications for research and clinical … 2011
Chlamydia and gonorrhea Better outreach to hard-to-reach
populations; high notification
and treatment … and transient ischemic attack;
chronic kidney disease; chronic
obstructive pulmonary disease;
and diabetes … In this context, several antibiotics administered together or a
combination of antibiotic treatment … Outside of the infection management literature, combinations of drug treatments and
procedures are also
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/stpra/stpraapf.pdf
June 02, 2025 - pt SSI risk
Gate4
Malnourished pt SSI risk
Gate5
Obese but not diabetes
pt SSI risk
Gate233 … obese pt
SSI risk
Event653
Diabetes and obese pt
Gate281
SSI risk for diabetes
and obese pt … Gate261
Pt with systemic steroid
use SSI risk
Event493
Other pt
Q:1e-007
Event495
Under treatment … (radiation, cheno)
Q:0
Gate264
Cancer not under
treatment SSI risk
Event496
Pt with systemic … use
Q:0.01
Gate265
SSI risk for pt with
systemic steriod use
Event498
Cured or not under
treatment
-
www.ahrq.gov/sites/default/files/2025-02/feeney-report.pdf
January 01, 2025 - NQF
is helping address this issue through its medication therapy management project. … This permitted rapid isolation of affected patients and application of
decolonization therapy to remove … Appropriate drug therapy management has significant impact on patient safety,
equity, effectiveness, … actually receive such treatment. … past 15 years, scientific knowledge of effective, evidence-based
therapies to treat substance use disorders
-
www.ahrq.gov/pqmp/implementation-qi/toolkit/antipsychotic/about.html
September 01, 2021 - new prescription for an antipsychotic medication and documentation of psychosocial care as first-line treatment … The recommended type and duration of the psychotherapy intervention for first-line treatment varies by … American Academy of Child & Adolescent Psychiatry (AACAP) also recommends psychotherapy as first-line treatment … intervals. 16 The AACAP practice parameters endorse American Psychiatric Association (APA)/American Diabetes … concurrent antipsychotics, with agreement that it should be generally avoided for initial or endpoint treatment
-
www.ahrq.gov/ncepcr/about/impact-stories/predictive-model.html
April 01, 2025 - Patients with MCC have two or more chronic conditions at the same time, such as diabetes, hypertension … " Our overarching hypothesis is that it's very hard to control your diabetes, your hypertension, and … will conduct a randomized controlled trial to compare patient-reported outcomes (such as reduction in treatment
-
www.ahrq.gov/research/findings/final-reports/ptmgmt/evaluation.html
July 01, 2018 - claims data will limit the total to individuals who have been diagnosed (or received some specific treatment … in a 114-day period in the acute phase and 180 days of therapy during a 231-day period in the continuation … phase), persistency of medication therapy (lack of a 90-day or longer gap in prescription refills during … (ADA PRP), Diabetes Quality Improvement Project (DQIP), and National Quality Forum (NQF) diabetes measurement … characteristic of a patient makes it more or less likely that this patient has a positive (or negative) treatment
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/pressure_ulcer_prevention/webinars/webinar6_pu_woundassesst.pdf
April 01, 2011 - • Treatment may be very different.
However—
• Not all wounds are clear cut. … • There may be diabetes and pressure
characteristics.
8
Moisture-Associated Skin Damage
• Also … pressure, or pressure in combination
with shear.”
12
NPUAP/EPUAP Pressure Ulcer Prevention and Treatment … • Evolution may be rapid, exposing
additional layers of tissue even with
treatment.
22
Source: … – Some people now say this is skin failure at life’s
end
36
Selecting Dressings and Treatment
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/4_TK3_T2c-SBAR_SST_Final.pdf
June 01, 2014 - . ________
B Background
¨ No ¨ Yes The resident has diabetes
¨ No ¨ Yes Other active diagnoses ( … _______________________________________________________
¨ No ¨ Yes Advance directives for limiting treatment
-
www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap6tab27.html
December 01, 2017 - Utilization of education and case management (ECM) visits among adults with diabetes or cardiovascular … Tribal
1.0
34.3%
3.0
Health conditions
CVD but not diabetes … 0.5
10.6%
4.5
CVD and diabetes
1.5
44.2%
3.4
Hypertension
1.1
36.9%
3.0
-
www.ahrq.gov/ncepcr/tools/confid-report/physfeedback.html
February 01, 2016 - site with each other and with a target goal for each of five specific clinical indicators relevant to diabetes … Hypothetical feedback report to convey primary care physicians’ performance in treating patients with diabetes … Case study illustrating the impact of clinician feedback reporting on quality of Type 2 diabetes care … receiving feedback showed significant improvements in care quality as measured by their adherence to treatment … treatments at nearly three times the rate of patients in the control group ( Guldberg, et al., 2011
-
www.ahrq.gov/cahps/quality-improvement/improvement-guide/6-strategies-for-improving/communication/strategy6i-shared-decisionmaking.html
April 01, 2023 - , clinicians will respect patients' goals and preferences and use them to guide recommendations and treatments … Elicit patients' goal and treatment preferences. … assessment of the extent to which patients are meaningfully involved in decisionmaking for medical tests and treatments … Patients’ participation in medical care: effects on blood sugar control and quality of life in diabetes … What role do patients wish to play in treatment decision making?
-
www.ahrq.gov/ncepcr/reports/2024-annual-report/spotlight-s9-hessler-jones-fichtenberg.html
May 01, 2024 - P9: Using a Mobile Health Tool to Improve Patient-Centered Care for Patients with Type 2 Diabetes
P10 … Preventive Care for Children
P12: Using a Televideo-based Training Model for Providers to Expand Treatment … take relevant social risk factor information into consideration at the point of care when developing treatment
-
www.ahrq.gov/priority-populations/observances/bhm/index.html
February 01, 2025 - Civilian Noninstitutionalized Population, 2017 , PDF (819 KB); HTML #518: Treatment and Monitoring … of Adults with Diagnosed Diabetes by Race/Ethnicity, 2015-2016 , PDF (663 KB); HTML #516: Any Use
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/overview/background/corebackgrnd.pdf
January 01, 2013 - Screening to identify health conditions for early intervention with effective
treatments is a primary … Dental treatment. … Diabetes. … submitted or identified as
documentation of underlying scientific soundness for the measures were therapy … vascular bypass and shunt, not heart.
62 Other diagnostic cardiovascular procedures.
63 Other non-OR therapeutic
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T2-Talking_with_Residents_Family_Members_Final.docx
October 01, 2016 - However, many older people get an antibiotic for UTI treatment even though they do not have these symptoms … Watchful waiting also means that if any symptoms of infection develop, antibiotic treatment can still … Watchful waiting also means that if any symptoms of infection develop, antibiotic treatment can still … In some cases, antibiotics may not clear up an infection completely and follow-up or additional treatment … infections
· Other drugs that your family member takes, such as Coumadin®
· Health problems, such as diabetes
-
www.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T1-Talking_with_Residents_Final.pdf
October 01, 2016 - individual history is also taken into account (for example, your history of UTIs) when
determining treatment … Watchful waiting also means that if any symptoms of infection develop,
antibiotic treatment can still … Watchful waiting also means that if any symptoms of infection develop,
antibiotic treatment can still … from your infection will be sent to a
lab and tested against a panel of antibiotics to find which treatment … antibiotic-resistant infections
• Other drugs that you take, such as Coumadin®
• Health problems, such as diabetes
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-5-working-with-safety-net-practices.pdf
September 01, 2015 - Reimbursement rules may create barriers to implementing new treatments
and care models. … create disincentives for practices to
provide indicated but expensive or time-consuming procedures or treatments … financial barriers that may
affect your practices’ ability to implement new approaches to care and new treatments … These conditions often result from environmental stressors, delayed access to health care and
treatment … Thus the RN is not diagnosing, but is
initiating treatment based on a diagnosis provided by the lab.